9DQ-18739-69231
2 vaccinations
3 coded responses
20 check-ins
3 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 768 / TX
- Registered
- 2020-12-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-28
Registered in v-safe
-
2020-12-28
Dose 1 — Moderna
- 2020-12-28
-
2020-12-29
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2020-12-31
- 2021-01-01
- 2021-01-02
-
2021-01-03
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-03
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
- 2021-01-04
-
2021-01-11
Survey response — day 14, dose 1MedDRA: Emergency care, Immediate post-injection reaction, Oral herpes, Swelling face — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Symptoms: Worst flare of cold sores I've ever had - rare and well controlled c medication. Topical tx and acute dose oral Acyclovir started within 2 hrs of sx's. Facial swelling began immediately and continued to spread. ER visit required by day 3. · Healthcare visit (other): Attempted urgent care and was advised to see ER due to weekend wait times.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-11
Report sent to call center — day 14, dose 1Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-01-26
Dose 2 — Moderna
-
2021-01-27
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-28
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Swelling, Itching · Fatigue or tirednessAdult check-in
-
2021-01-29
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling, Itching · NoneAdult check-in
- 2021-02-01
- 2021-02-02
- 2021-02-09
- 2021-02-17
- 2021-02-20
-
2021-02-24
Survey response — day 28, dose 2MedDRA: Migraine — Feeling: Good · Be unable to do your normal daily activitiesFree text: 5 day migraine requiring daily dose of breakthrough medication. On average, I use 2-4 doses per month.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-01
- 2021-03-04
- 2021-03-09
- 2021-03-11
- 2021-04-27
-
2021-07-27
Survey response — 6 months, dose 2MedDRA: Asthma — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Asthma-like respiratory symptomsMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-07-27
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-07-28
- 2021-08-02
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-28 | Moderna | |
| 2 | 2021-01-26 | Moderna |
Call center
3 call center cases
3 unsuccessful
Free text
Release 1 — day 14, dose 1
Symptoms: Worst flare of cold sores I've ever had - rare and well controlled c medication. Topical tx and acute dose oral Acyclovir started within 2 hrs of sx's. Facial swelling began immediately and continued to spread. ER visit required by day 3.
Healthcare visit (other): Attempted urgent care and was advised to see ER due to weekend wait times.
Release 4 — day 28, dose 2
Symptoms: 5 day migraine requiring daily dose of breakthrough medication. On average, I use 2-4 doses per month.
Release 9 — 6 months, dose 2
Symptoms: Asthma-like respiratory symptoms
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Emergency care | ✓ | ✓ | ✓ |
| HCVO | Office visit | ○ | ○ | ○ |
| SD | Asthma | ✓ | · | ✓ |
| SD | Emergency care | ✓ | ✓ | ✓ |
| SD | Immediate post-injection reaction | ✓ | ✓ | ✓ |
| SD | Migraine | ✓ | ✓ | ✓ |
| SD | Oral herpes | ✓ | ✓ | ✓ |
| SD | Swelling face | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release